Sales decline 7.78% to Rs 105.46 crore
Net profit of Tatva Chintan Pharma Chem declined 45.16% to Rs 5.21 crore in the quarter ended June 2024 as against Rs 9.50 crore during the previous quarter ended June 2023. Sales declined 7.78% to Rs 105.46 crore in the quarter ended June 2024 as against Rs 114.36 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales105.46114.36 -8 OPM %11.9718.66 -PBDT13.4719.43 -31 PBT6.8113.42 -49 NP5.219.50 -45Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Frankfurt Airport")
 "Kamala Harris, Kamala, Harris")
 "Information Technology")
 "bear market, stocks, sensex, nifty, loss, growth, crash, index")
 "India hockey schedule for Paris Olympics 2024")
